Categories Earnings, Technology

What to watch when Micron (MU) reports Q2 earnings

Analysts expect the company to report earnings of $0.37 per share on revenue of $4.6 billion

Micron Technology Inc. (NASDAQ: MU) is scheduled to report second quarter 2020 earnings results on Wednesday, March 25, after the closing bell. Analysts expect the company to report earnings of $0.37 per share on revenue of $4.6 billion.

The company has seen falling revenues over the past two quarters due to low demand for microprocessors. The second quarter results are expected to take a hit from the coronavirus outbreak which has disrupted the operations of most companies.

Micron derives a significant portion of its revenue from China and it remains to be seen how much of an impact the pandemic has had on its topline. Low prices and higher expenses are likely to weigh on margins in the quarter. Micron also faces tough competition in the industry.  

Looking ahead, Micron can be expected to benefit from the rising demand for data and the rollout of the 5G technology. As machine learning and artificial intelligence gain in prominence, the demand for data increases.

In the first quarter of 2020, Micron beat market estimates despite recording decreases in revenue and earnings. Revenues fell 35% to $5.14 billion while adjusted EPS dropped 84% to $0.48. The company saw double-digit revenue declines in all its segments.

For the second quarter, the company has guided for revenues of $4.5-4.8 billion and adjusted earnings of $0.29-0.41 per share. It will be worth watching how much of an impact the current situation will have on the third quarter outlook.

Micron’s stock has dropped 32% since the beginning of this year and 36% in the past one month. If the company beats estimates, the stock could see a pickup.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top